Patents Assigned to Centeon Pharma GmbH
  • Stabilized aqueous liquid preparations of blood coagulation factor XIII
    Patent number: 6084074
    Abstract: A stabilized aqueous liquid preparation of human blood coagulation factor XIII, prepared by recombinant DNA technology, from the group consisting of galactose, sucrose, sorbitol, glutamate, aspartate and histidine and where little reduction in biological activity occurs even when stored for a longer time.
    Type: Grant
    Filed: June 5, 1996
    Date of Patent: July 4, 2000
    Assignee: Centeon Pharma GmbH
    Inventors: Naoko Kato, Shuji Kondo
  • Method for the quantification of activated coagulation factor VII (FVIIa)
    Patent number: 5968759
    Abstract: The invention relates to a method for the quantification of coagulation factor VIIa (F VIIa) in FVIIa- or FVII/FVIIa-containing solutions by means of selective binding to immobilized soluble thromboplastin.
    Type: Grant
    Filed: October 16, 1996
    Date of Patent: October 19, 1999
    Assignee: Centeon Pharma GmbH
    Inventors: Jurgen Romisch, Hans-Arnold Stohr